Alexandre França Velo

Alexandre França Velo

Auto-generated profile, based on publicly available information

Alexandre França Velo

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2024 in Medical Image Analysis
Verified
Journal Article
Closed access
HXHuidong Xie
Huidong Xie
LGLiang Guo
Liang Guo
AVAlexandre Velo
Alexandre Velo
ZLZhao Liu
Zhao Liu
QLQiong Liu
Qiong Liu
CLChi Liu
Chi Liu

1 March 2016 in Flow Measurement and Instrumentation
Verified
Journal Article
Closed access
CMC.H. de Mesquita
C.H. de Mesquita
AVA.F. Velo
A.F. Velo
DCD.V.S. Carvalho
D.V.S. Carvalho
JMJ.F.T. Martins
J.F.T. Martins
MHM.M. Hamada
M.M. Hamada

1 March 2017 in Flow Measurement and Instrumentation
Verified
Journal Article
Closed access
AVA.F. Velo
A.F. Velo
MHM.M. Hamada
M.M. Hamada
DCD.V.S. Carvalho
D.V.S. Carvalho
JMJ.F.T. Martins
J.F.T. Martins
CMC.H. Mesquita
C.H. Mesquita

27 July 2023 in IEEE Transactions on Radiation and Plasma Medical Sciences
Verified
Journal Article
Closed access
AVAlexandre F. Velo
Alexandre F. Velo
PFPeng Fan
Peng Fan
HXHuidong Xie
Huidong Xie
XCXiongchao Chen
Xiongchao Chen
NBNabil Boutagy
Nabil Boutagy
CLChi Liu
Chi Liu
Single-photon emission computed tomography systems distinguish radionuclides by using multiple energy windows. For cadmium zinc telluride (CZT) detectors, the energy spectrum has a low-energy tail leading to additional crosstalk between the radionuclides. Previous work developed models to correct the scatter and crosstalk for CZT-based dedicated cardiac systems with similar 99mTc/123I tracer distributions. These models estimate the primary and scatter components by solving a set of equations employing the maximum-likelihood expectation–maximization approach. A penalty term is applied to ensure convergence. The present work estimates the penalty term for any 99mTc/123I activity level. An iterative approach incorporating Monte Carlo into the iterative image reconstruction loops was developed to estimate the penalty terms. We used SIMIND and extended cardiac-torso phantoms in this study. Distribution of tracers in the myocardial tissue and blood pool was varied to simulate a dynamic acquisition. Evaluations of the estimated and the real penalty terms were performed using simulations and large animal data. The myocardium to blood pool ratio was calculated using regions of interests in the myocardial tissue and the blood pool for quantitative analysis. All corrected images yielded a good agreement with the gold standard images. In conclusion, we developed a CZT crosstalk correction method for quantitative imaging of 99mTc/123I activity levels by dynamically estimating the penalty terms.

1 August 2018 in Flow Measurement and Instrumentation
Verified
Journal Article
Closed access
AVA.F. Velo
A.F. Velo
DCD.V.S. Carvalho
D.V.S. Carvalho
MHM.M. Hamada
M.M. Hamada

24 November 2025 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
AVAlexandre França Velo
Alexandre França Velo
LCLukas M. Carter
Lukas M. Carter
JHJohn L. Humm
John L. Humm
This study compares the subcellular dosimetry of 161 Tb and 177Lu, focusing on β⁻ particles, conversion electrons, and Auger electrons, and their relative contributions to cellular and subcellular damage. We aim to evaluate whether the higher emission yields of 161 Tb provide a therapeutic advantage, particularly for non-internalizing targeting agents in radiopharmaceutical therapy. A stochastic radionuclide decay model was implemented in MATLAB, incorporating internal conversion and Auger cascades and validated against ICRP 107. Geant4 track code simulations modeled electron transport in single-cell and voxelized membrane geometries. Energy deposition was assessed in the membrane, cytoplasm, and nucleus for 10,000 decays of each radionuclide. 161 Tb achieved similar nuclear energy deposition as 177Lu with about 25% of the decays, due to its higher yield of internal conversion. These conversion electrons contribute to nuclear damage playing a crucial role in cell damage. Auger electrons from 161 Tb additionally produced highly localized energy deposition at the cell membrane, that could also contribute to cell death. However, when normalizing for equivalent radiotoxicity to the bone marrow, around 75% of the 161 Tb decays provide a similar marrow absorbed dose as 177Lu, while still increasing the absorbed dose to the nucleus by approximately 18%. 161 Tb offers a more efficient subcellular energy deposition profile than 177Lu. It enables either similar therapeutic effect with fewer decays or enhanced nuclear absorbed dose under equivalent bone marrow toxicity. These results support the use of 161 Tb in targeted radiopharmaceutical therapy, particularly for isolated tumor cells and micrometastases.